FDARecall 100048Medicines
What to do
The FDA record of this recall has no instruction for consumers. Compare the lot codes below with your product. If they match, do not use it, and follow the notice of the firm or ask the store where you bought it. Talk to your pharmacist or doctor before stopping a medicine.Note from Recalls Watch, not agency text.
Read the official notice on accessdata.fda.gov (opens in a new tab)
Hazard
Why it was recalled
Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
FDA classification: Class III. Use is not likely to cause adverse health consequences. Status: Ongoing.
Is it yours? Products and codes
Type the lot, batch, date code, model number or UPC printed on the product. It is compared here, in your browser, with the codes this notice lists. The code is also added to the page address (?lot=…), so a copied link or result carries it.
General information on recalls from the agency: U.S. Food and Drug Administration (opens in a new tab).
Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in India, NDC 0378-1075-93.
- Lot or code
- Lot # 3228113, 3228114, 3228115, Exp Date: Oct 31, 2026; Lot # 3228120, 3228121, Exp Date: Nov 30, 2026.
- FDA recall number
- D-0049-2027
- Quantity
- 21,620 30-count bottles
Distribution (FDA): Nationwide in the USA.
About this record
- Issued by
- U.S. Food and Drug Administration
- Firm
- Viatris, Inc.
- Title
- Composed by Recalls Watch from fields of the record; FDA records have no title.